On air · 2 of 3 networks
ELEGEN
- elegenbio.com
- Healthcare & Life Sciences
- US
- 58 employees
ELEGEN’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 27. Watch ELEGEN with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 25 | Checked 30 Oct 2026 | See all 27 ads → | ||
| Meta | Not checked | — | |||
| Running | 34 | Ads on the Google Ads Transparency Center | Checked 28 Oct 2026 | Collect them with the API → |
ELEGEN has 25 live LinkedIn ads. We recorded 34 Google ads on 28 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 30 Oct 2025
Large, highly complex sequence designs pose big challenges for traditional cloning.😬 It’s time for a better option. ENFINIA Plasmid DNA delivers rapid clonal gene synthesis with unmatched speed, length, complexity, and high fidelity–all at an affordable price. ✅ Genes up to 15 kb, produced cell-free; plasmids up to 19 kb ✅ High-complexity, high GC designs ✅ NGS-verified ✅ Fast turnaround–as fast as 10 business days Confidence in every construct. Check out this app note: https://lnkd.in/g79M4bf9 #GeneSynthesis #CellFree #EnfiniaDNA #PlasmidDNA #SyntheticBiology #Biotech
- LINKEDIN · IMAGESince 5 Sept 2025
Built using Elegen’s patented cell-free DNA manufacturing technology, ENFINIA IVT Ready DNA templates offer a wide range of complexity without the pitfalls of plasmid cloning. Available Now.
- LINKEDIN · VIDEORecorded 17 Sept 2026
It's coming... high-complexity, high-quality cell-free DNA for a price lower than conventional low-quality gene fragments—and we’re inviting a few to take advantage of it now. 👉Apply for early access: https://lnkd.in/g2mWavku When speed, precision, complexity, and affordability converge, innovation accelerates.🚀This is the foundation for the next generation of synthetic DNA. #CellFreeSynthesis #SyntheticBiology #DNAmanufacturing #GeneticMedicine #CellFree #Innovation #GenIIDNA
- LINKEDIN · IMAGERecorded 17 Sept 2026
📊 New Application Note: Streamline mRNA Production with ENFINIA™ We’ve partnered with NEB to demonstrate how ENFINIA™ IVT Ready DNA works seamlessly with the HiScribe® T7 CleanCap® AG Kit—eliminating the need for cloning and linearization. 🔬 Key Findings: Equivalent Yield & Quality: Matches linearized plasmids in RNA yield, integrity, and purity. Superior Performance: Consistent yields at low mass inputs where plasmids often fail. Proven Functionality: Uniform poly(A) tails (LC-MS verified) and equivalent protein expression. Skip the plasmid bottleneck and accelerate your mRNA workflow. 🧬 📄 See the data here : https://lnkd.in/gp2kpVcp
- LINKEDIN · IMAGERecorded 17 Sept 2026
Learn key insghts into the capabilities of over 10 industry-leading DNA suppliers, including price, complexity, length, error rate and turnaround time. This detail-packed guide introduces next-gen gene synthesis who can produce longer, more complex linear DNA for plasmid assembly and enable developers to rapidly test a broader range of designs. Whether you are a seasoned expert or new to DNA synthesis, download the Next-Gen DNA Buyer’s Guide for valuable tips and strategies.
- LINKEDIN · IMAGERecorded 17 Sept 2026
Rapid cell-free protein expression? It’s here. Why waste weeks on cloning? Our Application Note proves that ENFINIA™ Linear DNA drives cell-free protein expression with yields comparable to plasmid DNA—but without the prep time. Skip the cloning. Start expressing. https://lnkd.in/gsRpEuFt
6 of 27 adsSign up to see every ELEGEN ad, filter by format and date, and get alerts on new ones.
See all 27 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.